{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:07:20Z","timestamp":1774566440926,"version":"3.50.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>\n                    Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, for which chemotherapy remains the cornerstone of treatment. Skin toxicity is a frequent adverse reaction to chemotherapy; however, progression from paronychia to necrotizing soft tissue infection of the fingertips is uncommon. This report describes the case of a 7-year-old child with ALL who developed paronychia following combination chemotherapy with vincristine and daunorubicin. The infection progressed to involve multiple fingertips as necrotizing soft tissue infection, a course facilitated by the patient's underlying severe neutropenia.\n                    <jats:italic>Raoultella ornithinolytica<\/jats:italic>\n                    was identified on blood culture. A structured, multistep nursing protocol was implemented, including local disinfection, ethacridine lactate compresses, topical application of recombinant human epidermal growth factor solution and mupirocin ointment, and local oxygen insufflation. This regimen resulted in significant improvement of the lesions. Within 7 days, pain subsided, edema reduced by more than 50%, and joint mobility was largely restored, with complete clinical resolution achieved within 14 days. This case highlights the importance of early recognition of chemotherapy-induced skin toxicity and the value of standardized stepwise wound management in improving functional outcomes. It provides a practical reference for managing this rare yet severe cutaneous adverse reaction in children and underscores the critical role of specialized nursing in supportive oncology care.\n                  <\/jats:p>","DOI":"10.3389\/fped.2025.1706507","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:31:39Z","timestamp":1770013899000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Necrotizing soft tissue infection of the fingertips secondary to paronychia in a leukemic child: a case report and warning"],"prefix":"10.3389","volume":"13","author":[{"given":"Nannan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghui","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1515\/dmpt-2023-0079","article-title":"Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia","volume":"38","author":"Gurieva","year":"2023","journal-title":"Drug Metab Pers Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/ijp.ijp_175_21","article-title":"Hand-foot syndrome induced by chemotherapy drug: case series study and literature review","volume":"54","author":"Zaiem","year":"2022","journal-title":"Indian J Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1468-3083.2006.01887.x","article-title":"Nail changes associated with chemotherapy in children","volume":"21","author":"Chen","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0190-9622(84)70032-6","article-title":"Nail changes secondary to systemic drugs or ingestants","volume":"10","author":"Daniel","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1365-2133.2001.04391.x","article-title":"Onychomadesis and onycholysis associated with capecitabine","volume":"145","author":"Chen","year":"2001","journal-title":"Br J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archinte.1974.00320210107015","article-title":"Nail growth: 30 years of observation","volume":"134","author":"Bean","year":"1974","journal-title":"Arch Intern Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/geronj\/23.4.557","article-title":"The effect of age on the rate of nail growth","volume":"23","author":"Lavelle","year":"1968","journal-title":"J Gerontol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/annonc\/mdg050","article-title":"Taxane-induced nail changes: incidence, clinical presentation and outcome","volume":"14","author":"Minisini","year":"2003","journal-title":"Ann Oncol"},{"key":"B10","first-page":"610","article-title":"Severe nail changes due to docetaxel treatment","volume":"13","author":"Rafi","year":"2003","journal-title":"Eur J Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1345\/aph.1C190","article-title":"Docetaxel-related skin, nail, and vascular toxicity","volume":"37","author":"Leonard","year":"2003","journal-title":"Ann Pharmacother"},{"key":"B12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jaad.2004.07.057","article-title":"Medical pearl: docetaxel-induced onycholysis","volume":"52","author":"Tinio","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2165\/00002018-199921030-00004","article-title":"Drug-induced nail disorders: incidence, management and prognosis","volume":"21","author":"Piraccini","year":"1999","journal-title":"Drug Saf"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.3760\/cma.j.cn112137-20231211-01347","article-title":"[Current situation and prospect of diagnosis and therapy of childhood acute leukemia in China]","volume":"104","author":"Yang","year":"2024","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1002\/cncr.34479","article-title":"Annual report to the nation on the status of cancer, part 1: national cancer statistics","volume":"128","author":"Cronin","year":"2022","journal-title":"Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3390\/cancers14082021","article-title":"Recent advances in treatment options for childhood acute lymphoblastic leukemia","volume":"14","author":"Malczewska","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3322\/caac.21665","article-title":"Recent progress in the treatment of cancer in children","volume":"71","author":"Butler","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B18","doi-asserted-by":"publisher","first-page":"841179","DOI":"10.3389\/fonc.2022.841179","article-title":"A novel risk defining system for pediatric T-cell acute lymphoblastic leukemia from CCCG-ALL-2015 group","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1002\/cncr.35481","article-title":"Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB-positive acute lymphoblastic leukemia patients: a retrospective multicenter study","volume":"130","author":"Zhang","year":"2024","journal-title":"Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1200\/JCO.22.01760","article-title":"Childhood acute lymphoblastic leukemia: results of the randomized acute lymphoblastic leukemia intercontinental-Berlin-Frankfurt-M\u00fcnster 2009 trial","volume":"41","author":"Campbell","year":"2023","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/S1470-2045(21)00328-4","article-title":"Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial","volume":"22","author":"Yang","year":"2021","journal-title":"Lancet Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.6004\/jnccn.2021.0042","article-title":"Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Brown","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"B24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/ctrv.2001.0243","article-title":"Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines","volume":"27","author":"Ronghe","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/17474086.2020.1770591","article-title":"A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia","volume":"13","author":"Capria","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1200\/JCO.1989.7.9.1260","article-title":"High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results","volume":"7","author":"Wolff","year":"1989","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00277-015-2389-9","article-title":"Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines","volume":"94","author":"Kim","year":"2015","journal-title":"Ann Hematol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/MPH.0000000000000206","article-title":"Mercaptopurine\/methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction","volume":"36","author":"Schmiegelow","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12885-022-09522-3","article-title":"Thiopurine enhanced ALL maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine\/methotrexate-based maintenance therapy in pediatric and adult patients (0\u201345 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol","volume":"22","author":"Toksvang","year":"2022","journal-title":"BMC Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1080\/14656566.2017.1391216","article-title":"Cytarabine and daunorubicin for the treatment of acute myeloid leukemia","volume":"18","author":"Murphy","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"B31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4103\/0378-6323.159950","article-title":"Dermatological adverse reactions to cancer chemotherapy","volume":"81","author":"Pavey","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/derm.2023.0258","article-title":"Toxic skin reactions should be differentiated from allergic reactions to chemotherapeutic drugs in children: a case series and review of the literature","volume":"35","author":"\u00d6zhan","year":"2024","journal-title":"Dermatitis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/ijpd.ijpd_103_24","article-title":"Spectrum of dermatology referrals from the pediatric cancer unit: a prospective observational study","volume":"26","author":"Agarwal","year":"2025","journal-title":"Indian J Paediatr Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.idc.2020.10.004","article-title":"Necrotizing soft tissue infections","volume":"35","author":"Stevens","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/01.CCM.0000129486.35458.7D","article-title":"The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections","volume":"32","author":"Wong","year":"2004","journal-title":"Crit Care Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3760\/cma.j.issn.0253-2727.2017.05.001","article-title":"[Consensus of Chinese experts on diagnosis of disseminated intravascular coagulation (version 2017)]","volume":"38","year":"2017","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"B37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5114\/ada.2020.100747","article-title":"Ecthyma gangrenosum as a serious complication of Pseudomonas aeruginosa infection in departments of paediatric oncology","volume":"38","author":"Ga\u0142\u0105zka","year":"2021","journal-title":"Postepy Dermatol Alergol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/wound.2023.0097","article-title":"Chemotherapy-mediated complications of wound healing: an understudied side effect","volume":"13","author":"S\u0142onimska","year":"2024","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12223-016-0490-7","article-title":"Raoultella spp.\u2014clinical significance, infections and susceptibility to antibiotics","volume":"62","author":"S\u0119kowska","year":"2017","journal-title":"Folia Microbiol (Praha)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1348-0421.13100","article-title":"Genomic characterization of New Delhi metallo-beta-lactamase-producing species of Morganellaceae, Yersiniaceae, and Enterobacteriaceae (other than Klebsiella) from Brazil over 2013\u20132022","volume":"68","author":"Camargo","year":"2024","journal-title":"Microbiol Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jpp.2023.05.001","article-title":"M\u00e9ningite bact\u00e9rienne n\u00e9onatale \u00e0 Raoultella planticola: \u00e0 propos d\u2019un cas","volume":"36","author":"Boukaka Kala","year":"2023","journal-title":"J P\u00e9diatrie Pu\u00e9ric"},{"key":"B42","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jiac.2014.05.005","article-title":"Clinical characteristics of Raoultella ornithinolytica bacteremia: a case series and literature review","volume":"20","author":"Haruki","year":"2014","journal-title":"J Infect Chemother"},{"key":"B43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijid.2016.02.014","article-title":"Emerging role of Raoultella ornithinolytica in human infections: a series of cases and review of the literature","volume":"45","author":"Seng","year":"2016","journal-title":"Int J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1128\/AAC.48.1.305-312.2004","article-title":"Genetic and biochemical characterization of the chromosomal class A beta-lactamases of Raoultella (formerly Klebsiella) planticola and Raoultella ornithinolytica","volume":"48","author":"Walckenaer","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"B45","first-page":"115","article-title":"Antibiotic susceptibility, serum response and surface properties of Klebsiella species","volume":"104","author":"Hostack\u00e1","year":"2001","journal-title":"Microbios"},{"key":"B46","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fped.2020.00362","article-title":"Raoultella ornithinolytica infection in the pediatric population: a retrospective study","volume":"8","author":"Pi","year":"2020","journal-title":"Front Pediatr"},{"key":"B47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/ph18020206","article-title":"Breakthrough advances in beta-lactamase inhibitors: new synthesized compounds and mechanisms of action against drug-resistant bacteria","volume":"18","author":"Huang","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/antibiotics12040755","article-title":"Antibacterial properties of ethacridine lactate and sulfmethoxazole loaded functionalized graphene oxide nanocomposites","volume":"12","author":"Jabri","year":"2023","journal-title":"Antibiotics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/biom15050650","article-title":"Tannic acid and ethacridine lactate attenuate markers of stress-induced intestinal barrier dysfunctions in murine small intestinal organoids","volume":"15","author":"Filipe Rosa","year":"2025","journal-title":"Biomolecules"},{"key":"B50","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/iwj.12057","article-title":"Efficacy of antiseptics containing povidone-iodine, octenidine dihydrochloride and ethacridine lactate against biofilm formed by Pseudomonas aeruginosa and Staphylococcus aureus measured with the novel biofilm-oriented antiseptics test","volume":"11","author":"Junka","year":"2014","journal-title":"Int Wound J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1524-4725.1992.tb03514.x","article-title":"Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers","volume":"18","author":"Falanga","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1008032","volume-title":"Wound Healing - Mechanisms and Pharmacological Interventions","author":"Tirma Gonz\u00e1lez-Mateo","year":"2025"},{"key":"B53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1128\/AAC.44.2.255-260.2000","article-title":"Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections","volume":"44","author":"Gisby","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"B54","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00268-003-7398-5","article-title":"Oxygen in wound healing and infection","volume":"28","author":"Gottrup","year":"2004","journal-title":"World J Surg"},{"key":"B55","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/167488a0","article-title":"Epidermal mitotic activity and oxygen tension","volume":"167","author":"Bullough","year":"1951","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/1523-1747.ep12285695","article-title":"Effect of oxygen on the growth of human epidermal keratinocytes","volume":"86","author":"Horikoshi","year":"1986","journal-title":"J Invest Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/jid.1966.182","article-title":"In vitro culture of human skin epithelial cells","volume":"47","author":"Karasek","year":"1966","journal-title":"J Invest Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1524-475x.1999.00053.x","article-title":"Effect of hyperbaric oxygen on human skin cells in culture and human dermal and skin equivalents","volume":"7","author":"Dimitrijevich","year":"1999","journal-title":"Wound Rep Reg"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1706507\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:31:41Z","timestamp":1770013901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1706507\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":58,"alternative-id":["10.3389\/fped.2025.1706507"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1706507","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"article-number":"1706507"}}